Literature DB >> 27294214

Perinatal outcome in fresh versus frozen embryo transfer in ART cycles.

Ali Aflatoonian1, Mohammad Ali Karimzadeh Maybodi1, Nastaran Aflatoonian1, Nasim Tabibnejad2, Mohammad Hossein Amir-Arjmand1, Mehrdad Soleimani2, Behrouz Aflatoonian3, Abbas Aflatoonian2.   

Abstract

BACKGROUND: Despite of higher pregnancy rate after frozen embryo transfer (FET) which is accepted by the majority of researches, the safety of this method and its effect on neonatal outcome is still under debate.
OBJECTIVE: The aim of this study was to evaluate pregnancy and neonatal outcome of FET compare to fresh cycles.
MATERIALS AND METHODS: In this study,1134 patients using fresh ET and 285 women underwent FET were investigated regarding live birth as primary outcome and gestational age, birth weight, gender, multiple status, ectopic pregnancy, still birth and pregnancy loss as secondary outcomes.
RESULTS: Our results showed that there is no difference between FET and fresh cycles regarding live birth (65.6% vs. 70.4% respectively). Ectopic pregnancy, still birth and abortion were similar in both groups. The mean gestational age was significantly lower among singletons in FET group compared to fresh cycles (p=0.047). Prematurity was significantly elevated among singleton infants in FET group (19.6%) in comparison to neonates born after fresh ET (12.8%) (p=0.037).
CONCLUSION: It seems that there is no major difference regarding perinatal outcome between fresh and frozen embryo transfer. Although, live birth is slightly increased in fresh cycles and prematurity was significantly increased among singleton infants in FET group.

Entities:  

Keywords:  Fresh embryo transfer; Frozen-thawed embryo transfer; Perinatal outcome; Pregnancy outcome

Year:  2016        PMID: 27294214      PMCID: PMC4899761     

Source DB:  PubMed          Journal:  Int J Reprod Biomed        ISSN: 2476-3772


Introduction

Introduction of embryo cryopreservation was a revolution in assisted reproductive technology (ART). Transfer of frozen embryos has been increasingly used during the past few decades, as it is a well-known part of ART nowadays. Frozen embryo transfer (FET) has several advantages and among them, the similar or even higher pregnancy and live birth rate compare to fresh cycles is of great importance (1). In addition, higher pregnancy rate after FET compared to fresh cycles was reported in some randomized trials and meta-analysis (1-3). The other benefit of FET is possibility of embryo transfer in a natural, non-stimulated cycle. It is shown that an artificial cycle may adversely affect endometrial receptivity leading to implantation failure (2-6). FET also is a useful method for preserving extra good quality embryos in women with good response to ovarian stimulation, increasing elective single embryo transfer and avoiding multi-gestations as well as ovarian hyperstimulation syndrome. Regardless of cryopreservation technique improvements, safety aspects and its impact on the health of children born are uncertain. Overall, it is showed that around 26% of newborns after ART were premature with a lower mean gestational age and 3.5 times higher risk of rising prematurity (7). It is reported in some investigations that embryo freezing has not a negative impact on perinatal outcome in terms of low birth weight (LBW), preterm labour and small for gestational age (SGA) (8-10). However, Wennerholm et al showed a higher prenatal mortality rate among singletons born after FET (10). In addition, FET increases the risk of being born large for gestational age (LGA) (10, 11). In terms of the risk for major congenital anomalies among children born after FET, there is no significant increase compared with children born after fresh embryo transfer (8, 12). One study reported a higher major malformation rate in the children born after FET following intra cytoplasmic sperm injection (ICSI) (13). This study is a continuation of our previous one and evaluates neonatal outcomes after FET compared with fresh embryo transfer cycles (14). In the former study, we found similar neonatal outcomes regarding prematurity, LBW, stillbirth, neonatal death and major congenital anomalies between FET and fresh ET groups in two infertility clinics.

Materials and methods

Study population To study the impact of FET on neonatal outcome, in a cohort study, 300 women using FET and 1150 women undergoing fresh embryo transfer were compared. Participants remained in the cohort until the livebirth occurred. The study was conducted at Yazd Madar Hospital over a 4-years period between December 2010 and December 2014. This study was approved by the Ethics Committee of Research and Clinical Center for Infertility, Yazd University of Medical Sciences. Data Collection Data were collected from the hospital records. In addition a telephone questionnaire consists of data on maternal and neonatal factors was administered by a trained nurse based on patients and their husbands’ information. Patient’s data included maternal age at birth, duration and causes of infertility. The primary outcome was live birth. The secondary outcome variables were perinatal data contains gestational age, birth weight, gender, twin status, stillbirth, ectopic pregnancy (EP) and spontaneous abortion. Outcomes were defined as followed: Preterm birth: <37 wks of gestational age at delivery. Small for gestational age (SGA): Birth weight less than 10th centile for gestational age. LBW: <2500 gr at birth. Stillbirth: Fetal death more than 20 wks of gestational age. EP: Finding of extra uterine pregnancy by laparoscopy or ultrasound. Spontaneous abortion: Loss of pregnancy before 20 wks of gestation. The increased miscarriage rate in this survey is thought to be due to pregnancy loss calculation, according to chemical pregnancy in women with an initial positive β-hCG test. Ovarian stimulation protocol Two protocols were used for ovarian stimulation: GnRH agonist long protocol and GnRH antagonist protocol as described previously (15, 16). Embryo cryopreservation techniques and transfer protocols All embryos were morphologically evaluated on the second day after oocyte retrieval. Number of blastomeres and cytoplasmic fragmentation was assessed. Two embryos with good or excellent quality were transferred in fresh cycles, only in women over the age of 40 and regarding patients’ request, 3 embryos were transferred. All the extra embryos with less than 30% fragmentation were cryopreserved by vitrification method. During two step loading protocols, embryos were loaded with equilibration solution containing 7.5% dimethyl sulfoxide (DMSO) (Sigma-Aldrich) and 7.5% ethylene glycol (EG) (Sigma-Aldrich, Steinheim, Germany) in Ham’s F-10 media supplemented with 20% patient serum for 5-15 min at room temperature. Once the primary shrinkage and recovery, embryos were aspirated and placed into the vitrification solution 15% EG, 15% DMSO and 0.5 M sucrose (Merck, Darmstadt, Germany) in Ham’s F-10 medium supplemented with 20% patient serum for 50-60 sec at room temperature. The embryos then were loaded by a thin glass capillary tube into the cryotop and the samples were immediately submerged into liquid nitrogen for at least 2 months. For thawing, cryoprotectants were removed step by step using embryo thawing media (Vitrolife, Goteborg, Sweden) by insertion the Cryotop in thawing solution (1 M sucrose) for 50-60 sec and next into dilution solution (0.5 M sucrose) for 3 min, after that embryos placed in another dilution solution of 0.25 M sucrose for 3 min, all at room temperature. The thawed embryos were placed 4-5 times into washing solution (Ham’s F-10 +20% serum) before incubation. After embryo transferred to culture medium, they considered morphologically survived by 50% or more intact blastomeres and no injury to zonapllucida. Only intact or partly damaged embryos were transferred. Endometrial preparation was performed using oral Estradiol Valerat (Estradiol Valerate, Aburaihan CO, Tehran, Iran) at the dose of 6 mg per day from the second day of menstrual cycle until the endometrial thickness reached more than 8 mm, and then 100 mg progesterone in oil (Progesterone, Aburaihan CO, Tehran, Iran) was injected or Cyclogest 400 mg (Collins & Co. Ltd, UK) was used daily. Estradiol and progesterone administered continuously until observation of fetal heart activity by ultrasound. Embryo transfer was done 3 days after the beginning of progesterone injection using a Labotect (Labotect, Gottingen, Germany) or Cook catheter (Laboratoire CCD, France). Statistical analysis The Statistical Package for the Social Science version 20 for windows (SPSS Inc, Chicago. IL, USA) was used for data analysis. Differences between normally distributed continuous variables were measured by Student’s t test. The Chi-square test was used to compare non-continues variables. Statistical significant was set at a p<0.05. Adverse or protective effects of FET on perinatal outcome versus fresh cycles are expressed as odds ratio.

Results

1150 women using fresh ET and 300 women undergoing FET were initially enrolled the study. Sixteen women in fresh and 15 women in FET group were excluded because of refusing to participate or loss to follow up. Patents basic characteristics were not significantly different (Table I).
Table I

Baseline characteristics of the patients in FET and Fresh cycle groups

Variable FET (n=285) Fresh (n=1134) p-value
Maternal age (years)30.53 ± 4.5130.46 ± 4.840.907
Infertility duration* (years)7 (IQR=5)7 (IQR=6)0.172
Causes of infertility
Male factor 126 (44.2%)512 (45.1%)0.915
Ovary factor 64 (22.5%)226 (19.9%)
Tubal factor 32 (11.2%)129 (11.4%)
Endometriosis3 (1.1%)13 (1.1%)
Mixed60 (21.1%)254 (22.4%)

Data are presented as mean ± SD.

FET: Frozen embryo transfer

Median (Interquartile range).

It is shown that FET cannot increase the chance of live birth (65.6% vs. 70.4% in fresh group) OR=0.80 (CI: 0.61-1.05) (p=0.120) (Table II). 79.1% of pregnancies in FET group were singleton, whereas 18.7% were twin and 2.2% were triple. It was observed that 69.4% of live births in fresh cycles lead to singleton pregnancies while twins and triples were 26.7% and 3.9% respectively (Table II). We found the comparable results regarding EP (0.7% vs. 0.9%), abortion (chemical and clinical pregnancy) (32.3% vs. 27.5%), and still birth (1.4% vs. 1.2%), in FET and fresh cycles respectively (Table II).
Table II

Pregnancy outcome in FET women versus fresh cycle group

Variable FET Fresh Odds ratio (95% CI) p-value
Live birth187 (65.6%)798 (70.4%)0.80 (0.61-1.05)0.120
Singletons148 (79.1%)554 (69.4%)1.67 (1.13-2.45)0.009
Twins35 (18.7%)213 (26.7%)0.63 (0.42-0.94)0.025
Triples4 (2.2%)31 (3.9%)0.54 (0.18-1.55)0.253
Ectopic pregnancy2 (0.7%)10 (0.9%)0.79 (0.17-3.64)0.767
Pregnancy loss92 (32.3%)312 (27.5%)1.25 (0.94-1.66)0.111
Still birth4 (1.4)14 (1.2)1.13 (0.37-3.48)0.820

Data are presented as n (%).

FET: Frozen embryo transfer

The mean gestational age at the time of delivery was lower among singletons in FET group than fresh cycles (37.34±2.47 vs. 37.77±1.90 respectively) and the difference was statistically significant (p=0.047). Whereas, the mean gestational age of twin and triple pregnancies was significantly higher in FET group compared to fresh embryo transfer. There were no statistical differences in the mean live birth along with singleton and twin newborns between groups. Only triple pregnancies had a considerable higher birth weight in FET versus fresh cycles (p=0.028) (Table III).
Table III

Mean and standard deviation of gestational age and birth weight of two groups

Variable FET
Fresh
p-value
Number Mean±SD Number Mean±SD
Gestational age18737.04 ± 2.4079836.75 ± 2.830.190
Singletons14837.34 ± 2.4755437.77 ± 1.900.047
Twins3535.94 ± 1.7821334.78 ± 2.910.002
Triples435.75 ± 0.503131.90 ± 3.980.000
Birth weight1872798.40 ± 661.347982687.55 ± 753.910.046
Singletons1482902.43 ± 663.585542915.96 ± 664.530.826
Twins352389.71 ± 483.482132243.66 ± 648.270.204
Triples42525.00 ± 556.02311655.48 ± 725.800.028

Data are presented as mean ± SD.

FET: Frozen embryo transfer

As it is presented in table IV, prematurity was significantly increased among singleton infants in FET group in comparison with neonates born after fresh ET (p=0.037). However, the percentage of premature twins was slightly elevated in fresh group. All of triple pregnancies in FET group and 90.3% in fresh cycles were premature. There was no statistically difference between two groups regarding SGA. Nevertheless, the proportion of LBW newborns were significantly decreased in twin and triple pregnancies in FET compared with fresh group. We observed the same sex ratio among singletons, twins and triples in FET group as well as fresh cycles (Table V).
Table IV

Prematurity, LBW and SGA in FET women versus fresh cycle group

Variable FET Fresh Odds ratio (95% CI) p-values
Prematurity56 (29.9%)244 (30.6%)0.97 (0.68-1.37)0.866
Singletons29 (19.6%)71 (12.8%)1.65 (1.03-2.66)0.037
Twins23 (65.7)145 (68.1)0.89 (0.42-1.91)0.782
Triples4 (100%)28 (90.3%)1.10 (0.98-1.24)1.000
LBW48 (25.7%)259 (32.5%)0.71 (0.50-1.03)0.072
Singletons33 (22.3%)105 (19%)1.22 (0.78-1.90)0.364
Twins14 (40%)128 (60.1%)0.44 (0.21-0.91)0.029
Triples1 (25%)26 (83.9%)0.06 (0.00-0.74)0.028
SGA31 (16.6%)180 (22.6%)0.68 (0.44-1.03)0.074
Singletons21 (14.2%)90 (16.2%)0.85 (0.51-1.42)0.543
Twins9 (25.7%)77 (36.2%)0.61 (0.27-1.37)0.233
Triples1 (25%)13 (41.9%)0.46 (0.04-4.95)0.523

Data are presented as numbers (%).

FET: Frozen embryo transfer

LBW: Low birth weight

SGA: Small for gestational age

Table V

Sex ratio in FET women versus fresh cycle group

Variable FET Fresh Odds ratio (95% CI) p-values
Sex
     Boy99 (52.9%)415 (52%)1.03 (0.75-1.42)0.818
     Girl88 (47.1%)383 (48%)
Singletons
     Boy81 (54.7)299 (54)1.03 (0.71-1.48)0.869
     Girl67 (45.3%)255 (46%)
Twins
     Boy16 (45.7%)105 (49.3%)0.86 (0.42-1.77)0.695
     Girl19 (54.3%)108 (50.7%)
Triples
     Boy2 (50%)11 (35.5%)1.81 (0.22-14.75)0.576
     Girl2 (50%)20 (64.5%)

Data are presented as numbers (%).

FET: Frozen embryo transfer

Baseline characteristics of the patients in FET and Fresh cycle groups Data are presented as mean ± SD. FET: Frozen embryo transfer Median (Interquartile range). Pregnancy outcome in FET women versus fresh cycle group Data are presented as n (%). FET: Frozen embryo transfer Mean and standard deviation of gestational age and birth weight of two groups Data are presented as mean ± SD. FET: Frozen embryo transfer Prematurity, LBW and SGA in FET women versus fresh cycle group Data are presented as numbers (%). FET: Frozen embryo transfer LBW: Low birth weight SGA: Small for gestational age Sex ratio in FET women versus fresh cycle group Data are presented as numbers (%). FET: Frozen embryo transfer

Discussion

In this study, we compared perinatal outcomes after FET with fresh ET cycles. The main finding was that live birth slightly increased in fresh group without significant difference. As secondary outcomes, EP, spontaneous abortion and still birth did not differ between FET and fresh cycles. In our previous study, live birth regardless singletons or multiples was significantly lower in FET group (14). However in another studies chemical and clinical pregnancy rate as well as live birth in both singleton and multiple pregnancies did not vary between FET and fresh groups (11, 17). An important factor about developing live birth after fresh cycles may be transfer of top quality embryos. As freezing and thawing procedures are harmful for embryos, it is expected that only 30-48% of embryos survive intact after cryopreservation (18). However a recent study indicated that 66% of cycles present top quality embryo morphology after thawing (12). This argument is required to confirm by a prospective study using embryos with the same quality in both fresh and FET cycles. Similar to older reports, our data showed no difference between two groups regarding spontaneous abortion (13, 19, 20). However, we found a significant miscarriage rate between FET and fresh group in our previous study (14). Similarly, a higher rate of spontaneous abortion ≤12 weeks in frozen-thawed embryos and 14% greater risk of miscarriage in thawed blastocyst transferred were reported compared to fresh ET (21, 22). Regarding ectopic pregnancy, there was no significant difference between FET and fresh cycles in current and our earlier research. Likewise, Levi et al and Jun found no significant alteration in EP between FET and fresh cycles (21, 23). Nevertheless, two other studies demonstrated that risk of EP significantly decrease by transfer of frozen blastocysts compared with fresh ones (24, 25). Similar to another study, the hazard of still birth did not differ significantly between two groups (10). In contrast to other publications our data revealed that FET significantly increase the risk of prematurity and LBW in singleton pregnancies (8, 10, 26, 27). In our earlier study, prematurity and LBW were comparable between groups (14). Nevertheless, a meta-analysis on observational studies comparing perinatal outcome of FET and fresh cycles, confirmed that FET reduce the risk of LBW and prematurity in singletons (9). Conversely, another research demonstrated that LBW and prematurity have not any significant difference between fresh and FET groups among singleton and multiple pregnancies (11, 26). Shi et al also found that babies delivered after FET was significantly heavier than those born after fresh cycles in both singleton and multiple pregnancies (11). Another survey indicated that prematurity and LBW are 1.3 times and 1.5 times more common respectively in single tone pregnancies after fresh embryo transfer compared with FET. It is also showed that prematurity increased among couples with female factor infertility compared to male factors. However, in twins, preterm birth and LBW were decreased in ICSI and FET cycles and among couples with male factor infertility (28). It is showed in animal studies that both induction of ovulation and type of embryo culture medium disturb genomic imprinting and affect fetal outcome (29, 30). Recently, it is reported in human that the type of culture medium is significantly related to birth weight (31). Otherwise, another study did not find any significant difference between two compared culture medium regarding mean birth weight, but babies born after cryopreservation had a significant higher birth weight than fresh group (32, 33). The authors believed that this alteration can be due to the interaction between cryo-protectants with the main enzyme interfered in epigenetic reprogramming, lead to normalization of the imprinting process (34). In accordance with some studies, we found that singleton and multiple pregnancies subsequent of FET showed a lower percentage of SGA newborns, but the difference was not statistically significant (9, 10, 26). In current study we did not find any difference in sex ratio (male/female) between fresh cycle and FET group. In our previous survey only singleton pregnancies showed a significant higher sex ratio in FET group compare to fresh embryo transfer (14). Similar to our finding, Wennerholm et al could not show any statistical significant difference in the sex ratio between singleton born after FET, fresh IVF/ICSI and spontaneous conception (10).

Conclusion

In conclusion, according to our results, it seems that there is no major difference regarding perinatal outcome between fresh and frozen embryo transfer. Our data revealed that live birth did not differ significantly between FET and fresh cycles with a slight elevation in fresh group. The other outcomes including EP, spontaneous abortion (chemical and clinical pregnancy), still birth and SGA were similar in both groups. Our findings showed that FET significantly increases the risk of prematurity and LBW in singleton pregnancies.
  33 in total

Review 1.  The endometrium in stimulated cycles for IVF.

Authors:  Claire Bourgain; Paul Devroey
Journal:  Hum Reprod Update       Date:  2003 Nov-Dec       Impact factor: 15.610

2.  Correlation between embryological factors and pregnancy rate: development of an embryo score in a cryopreservation programme.

Authors:  Miquel Solé; Josep Santaló; Ignacio Rodríguez; Montse Boada; Buenaventura Coroleu; Pere N Barri; Anna Veiga
Journal:  J Assist Reprod Genet       Date:  2010-11-02       Impact factor: 3.412

3.  Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles.

Authors:  Abbas Aflatoonian; Fatemeh Mansoori Moghaddam; Mehri Mashayekhy; Farnaz Mohamadian
Journal:  J Assist Reprod Genet       Date:  2010-10-01       Impact factor: 3.412

4.  Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000.

Authors:  Yueping Alex Wang; Elizabeth A Sullivan; Deborah Black; Jishan Dean; Joanne Bryant; Michael Chapman
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

5.  Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group.

Authors:  Ulla-Britt Wennerholm; Anna-Karina Aaris Henningsen; Liv Bente Romundstad; Christina Bergh; Anja Pinborg; Rolv Skjaerven; Julie Forman; Mika Gissler; Karl Gösta Nygren; Aila Tiitinen
Journal:  Hum Reprod       Date:  2013-07-05       Impact factor: 6.918

6.  Frozen-thawed blastocyst transfer reduces ectopic pregnancy risk: an analysis of single embryo transfer cycles in Japan.

Authors:  Osamu Ishihara; Akira Kuwahara; Hidekazu Saitoh
Journal:  Fertil Steril       Date:  2011-03-05       Impact factor: 7.329

7.  Ectopic pregnancy rates with frozen compared with fresh blastocyst transfer.

Authors:  Sunny H Jun; Amin A Milki
Journal:  Fertil Steril       Date:  2007-04-16       Impact factor: 7.329

Review 8.  Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis.

Authors:  Abha Maheshwari; Shilpi Pandey; Ashalatha Shetty; Mark Hamilton; Siladitya Bhattacharya
Journal:  Fertil Steril       Date:  2012-06-13       Impact factor: 7.329

9.  Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles.

Authors:  F Belva; S Henriet; E Van den Abbeel; M Camus; P Devroey; J Van der Elst; I Liebaers; P Haentjens; M Bonduelle
Journal:  Hum Reprod       Date:  2008-07-14       Impact factor: 6.918

10.  Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology.

Authors:  Maryam Eftekhar; Abbas Aflatoonian; Farnaz Mohammadian; Tahereh Eftekhar
Journal:  Arch Gynecol Obstet       Date:  2012-12-04       Impact factor: 2.344

View more
  8 in total

1.  Reduced live birth rates in frozen versus fresh single cleavage stage embryo transfer cycles: A cross -sectional study.

Authors:  Wan Tinn Teh; Alex Polyakov; Claire Garrett; David Edgar; John Mcbain; Peter Adrian Walton Rogers
Journal:  Int J Reprod Biomed       Date:  2020-07-22

2.  Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study.

Authors:  Abbas Aflatoonian; Mahnaz Mansoori-Torshizi; Maryam Farid Mojtahedi; Behrouz Aflatoonian; Mohammaad Ali Khalili; Mohammad Hossein Amir-Arjmand; Mehrdad Soleimani; Nastaran Aflatoonian; Homa Oskouian; Nasim Tabibnejad; Peter Humaidan
Journal:  Int J Reprod Biomed (Yazd)       Date:  2018-01

3.  Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer? An RCT.

Authors:  Ashraf Aleyasin; Marzieh Aghahosseini; Leili Safdarian; Maryam Noorzadeh; Parvin Fallahi; Zahra Rezaeian; Sedighe Hoseinimosa
Journal:  Int J Reprod Biomed (Yazd)       Date:  2017-02

4.  Effect of quercetin on the number of blastomeres, zona pellucida thickness, and hatching rate of mouse embryos exposed to actinomycin D: An experimental study.

Authors:  Hamid Reza Sameni; Sara Sadat Javadinia; Manouchehr Safari; Mohammad Hasan Tabrizi Amjad; Nasrin Khanmohammadi; Houman Parsaie; Sam Zarbakhsh
Journal:  Int J Reprod Biomed       Date:  2018-02

5.  Comparison of letrozole with gonadotropin-releasing hormone agonist in frozen embryo transfer after recurrent implantation failure: An RCT.

Authors:  Nayere Khadem Ghaebi; Malihe Mahmoudiniya; Mona Najaf Najafi; Elnaz Zohdi; Matin Attaran
Journal:  Int J Reprod Biomed       Date:  2020-02-27

6.  Alterations of miR-16, miR-let-7a and their target genes expression in human blastocysts following vitrification and re-vitrification.

Authors:  Maryam Daneshvar; Mansoureh Movahedin; Mohammad Salehi; Mehrdad Noruzinia
Journal:  Reprod Biol Endocrinol       Date:  2021-10-09       Impact factor: 5.211

7.  Comparison of Outcomes of IVF Cycles Between Transferred Frozen Thawed Embryos and Fresh Embryos by a 2 Year Survey.

Authors:  Ensieh Shahrokh-Tehraninejad; Zeynab Vosoog; Fatemeh Farajzadeh-Vajari
Journal:  J Reprod Infertil       Date:  2017 Oct-Dec

8.  Derivation of new human embryonic stem cell lines (Yazd1-3) and their vitrification using Cryotech and Cryowin tools: A lab resources report.

Authors:  Fatemeh Akyash; Somayyeh Sadat Tahajjodi; Ehsan Farashahi Yazd; Fatemeh Hajizadeh-Tafti; Fatemeh Sadeghian-Nodoushan; Jalal Golzadeh; Hassan Heidarian Meimandi; Harry Moore; Behrouz Aflatoonian
Journal:  Int J Reprod Biomed       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.